Uncategorized
Publication Exclusive: Fallout from failed clinical trials poses challenges to companies
So far in 2015, four different ophthalmic products in phase 3 clinical trials failed to meet their primary endpoints. Ocular Surgery News spoke with three of these companies to find out what happened and how they responded. Their stories offer a telling glimpse at the challenges and opportunities companies face when endpoints are missed in clinical trials as part of the overall innovation cycle.“Private companies often simply learn from their experience and make appropriate adjustments to their research and business plan. They continue on as long as their investors are (Read more...)